Lung Cancer       

Lung Cancer        image

Home » FOI request log » Lung Cancer       

FOI REFERENCE: 24161   FOI DATE: 11th June 2024      

Q1. How many non-small cell lung cancer (NSCLC) patients were treated in the past 3 months with:

  • ALK Inhibitors (Alectinib, Brigatinib, Ceritinib, Crizotinib, Lorlatinib) 5 patients
  • Amivantamab 0 patients
  • Atezolizumab Monotherapy 12 patients
  • Atezolizumab + Bevacizumab + Carboplatin + Paclitaxel 0 patients
  • Dabrafenib + Trametinib  0 patients
  • Docetaxel monotherapy or in combination with Carboplatin/Cisplatin * patients
  • Durvalumab * patients
  • Gemcitabine 0 patients
  • Nitedanib + Docetaxel 0 patients
  • Nivolumab  6 patients
  • Osimertinib 22 patients
  • Other EGFR Inhibitors (Afatinib, Erlotinib, Gefitinib, Dacomitinib, Mobocertinib)  * patients
  • Paclitaxel * patients
  • Pembrolizumab Monotherapy  32 patients
  • Pembrolizumab + Paclitaxel + Platinum (Carboplatin/Cisplatin)  * patients
  • Pembrolizumab + Pemetrexed + Platinum (Carboplatin/Cisplatin)  6 patients
  • Pemetrexed + Platinum (Carboplatin/Cisplatin)  10 patients
  • RET Inhibitors (Pralsetinib, Selpercatinib)  * patients
  • Sotorasib * patients
  • Tepotinib  * patients
  • Vinorelbine monotherapy or in combination with Carboplatin/Cisplatin  8 patients
  • Other active systemic anti-cancer therapy Not applicable
  • Palliative care only  96 patients

Q2. How many patients were treated for Squamous non-small cell lung cancer (Sq NSCLC) ONLY in the past 3 months with:

  • Atezolizumab monotherapy  * patients
  • Durvalumab 0 patients
  • Gemcitabine * patients
  • Nivolumab  * patients
  • Osimertinib  * patients
  • Pembrolizumab (Keytruda) Mono  12 patients
  • Pembrolizumab + Paclitaxel + Platinum (Carboplatin/Cisplatin)  * patients
  • Paclitaxel  0 patients
  • Vinorelbine monotherapy or in combination with Carboplatin/Cisplatin   * patients
  • Other active systemic anti-cancer therapy (SACT)
  • Palliative care only  27 patients

*This relates to low numbers between 1 and 4. Under section 40 (ii) of the Freedom of Information Act 2000, statistically low numbers that potentially identify personal data are required to be withheld because of the Trusts obligation to protect personal data under the Data Protection Act 2018

Print this page
Email this page